Extracranial Melanoma Metastases Treated with Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibitors
Kamran A. Ahmed(Moffitt Cancer Center), J.J. Caudell(Moffitt Cancer Center), S. Kim(Moffitt Cancer Center), Nikhil I. Khushalani(Roswell Park Comprehensive Cancer Center), B.A. Perez(Moffitt Cancer Center), Andrew Keller(University of Central Florida), Y.A. Abuodeh(Moffitt Cancer Center), L.B. Harrison(Moffitt Cancer Center), A.O. Naghavi
International Journal of Radiation Oncology*Biology*Physics
September 23, 2017
Cited by 0
Related Papers
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
|JAMA Oncology|2015|656
Proinflammatory Role for let-7 MicroRNAS in Experimental Asthma
|Journal of Biological Chemistry|2010|240
Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline
|Journal of Clinical Oncology|2020|221
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
|International Journal of Radiation Oncology*Biology*Physics|2023|18
Soft tissue head and neck sarcoma: experience of a tertiary referral centre over a 15-year period
|The Journal of Laryngology & Otology|2019|8